Should the choice of BOIN design parameter p.tox only depend on the target DLT rate?
arxiv(2024)
摘要
When the early stopping parameter n.earlystop is relatively small or the
cohortsize value is not optimized via simulation, it may be better to use p.tox
< 1.4 * target.DLT.rate, or try out different cohort sizes, or increase
n.earlystop, whichever is both feasible and provides better operating
characteristics. This is because if the cohortsize was not optimized via
simulation, even when n.earlystop = 12, the BOIN escalation/de-escalation rules
generated using p.tox = 1.4 * target.DLT.rate could be exactly the same as
those calculated using p.tox > 3 * target.DLT.rate, which might not be
acceptable for some pediatric trials targeting 10
3+3 design stops the dose finding process when 3 patients have been treated at
the current dose level, 0 DLT has been observed, and the next higher dose has
already been eliminated. If additional 3 patients were required to be treated
at the current dose in the situation described above, the corresponding
boundary table could be generated using BOIN design with target DLT rates
ranging from 18
39
parameters also need to satisfy a set of conditions.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要